Evidence map›Paper›PMID 42179048›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2026

Design and Pictet-Spengler enabled synthesis of carboxamide-substituted imidazo[1,2-

Joydeep Chatterjee, Gaurav Joshi, Vibhu Jha, Shivkanya M Bhujbal, Shivani Rathour, Sanjana Majumdar, Muhammad Wahajuddin, Prasad V Bharatam, Raj Kumar

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joydeep ChatterjeeLaboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.
Gaurav JoshiDepartment of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar, India.
Vibhu JhaInstitute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford, UK.ORCID 0000-0002-1168-7480
Shivkanya M BhujbalDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India.
Shivani RathourLaboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.
Sanjana MajumdarLaboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.
Muhammad WahajuddinInstitute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford, UK.
Prasad V BharatamDepartment of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India.
Raj KumarLaboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.ORCID 0000-0001-5113-6627

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we report the Pictet-Spengler enabled synthesis of a series of eighteen carboxamide-substituted imidazo[1,2-

Indexed as

Antineoplastic AgentsDrug DesignImidazolesProtein Kinase InhibitorsQuinoxalinesTubulinTubulin ModulatorsAmidesCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorErbB ReceptorsHumansMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipAmidesAntineoplastic AgentsEGFR protein, humanErbB ReceptorsImidazolesProtein Kinase InhibitorsQuinoxalinesTubulinTubulin Modulatorsdual-target anticancer agentsEGFR kinase inhibitionmolecular docking and dynamicsROS-mediated apoptosistubulin polymerisation

Identifiers

PMID42179048
PMCPMC13202676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.